Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data

Kan Li, Wenyaw Chan, Rachelle S. Doody, Joseph Quinn, Sheng Luo

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Identifying predictors of conversion to Alzheimer's disease (AD) is critically important for AD prevention and targeted treatment. Objective: To compare various clinical and biomarker trajectories for tracking progression and predicting conversion from amnestic mild cognitive impairment to probable AD. Methods: Participants were from the ADNI-1 study. We assessed the ability of 33 longitudinal biomarkers to predict time to AD conversion, accounting for demographic and genetic factors. We used joint modelling of longitudinal and survival data to examine the association between changes of measures and disease progression. We also employed time-dependent receiver operating characteristic method to assess the discriminating capability of the measures. Results: 23 of 33 longitudinal clinical and imaging measures are significant predictors of AD conversion beyond demographic and genetic factors. The strong phenotypic and biological predictors are in the cognitive domain (ADAS-Cog; RAVLT), functional domain (FAQ), and neuroimaging domain (middle temporal gyrus and hippocampal volume). The strongest predictor is ADAS-Cog 13 with an increase of one SD in ADAS-Cog 13 increased the risk of AD conversion by 2.92 times. Conclusion: Prediction of AD conversion can be improved by incorporating longitudinal change information, in addition to baseline characteristics. Cognitive measures are consistently significant and generally stronger predictors than imaging measures.

Original languageEnglish (US)
Pages (from-to)361-371
Number of pages11
JournalJournal of Alzheimer's Disease
Volume58
Issue number2
DOIs
StatePublished - 2017

Fingerprint

Alzheimer Disease
Biomarkers
Demography
Aptitude
Temporal Lobe
Neuroimaging
ROC Curve
Disease Progression
Joints

Keywords

  • ADNI
  • joint modeling
  • longitudinal and survival data
  • mild cognitive impairment
  • prediction

ASJC Scopus subject areas

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data. / Li, Kan; Chan, Wenyaw; Doody, Rachelle S.; Quinn, Joseph; Luo, Sheng.

In: Journal of Alzheimer's Disease, Vol. 58, No. 2, 2017, p. 361-371.

Research output: Contribution to journalArticle

Li, Kan ; Chan, Wenyaw ; Doody, Rachelle S. ; Quinn, Joseph ; Luo, Sheng. / Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data. In: Journal of Alzheimer's Disease. 2017 ; Vol. 58, No. 2. pp. 361-371.
@article{ba55a15d651448d18836c4575ffedfda,
title = "Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data",
abstract = "Background: Identifying predictors of conversion to Alzheimer's disease (AD) is critically important for AD prevention and targeted treatment. Objective: To compare various clinical and biomarker trajectories for tracking progression and predicting conversion from amnestic mild cognitive impairment to probable AD. Methods: Participants were from the ADNI-1 study. We assessed the ability of 33 longitudinal biomarkers to predict time to AD conversion, accounting for demographic and genetic factors. We used joint modelling of longitudinal and survival data to examine the association between changes of measures and disease progression. We also employed time-dependent receiver operating characteristic method to assess the discriminating capability of the measures. Results: 23 of 33 longitudinal clinical and imaging measures are significant predictors of AD conversion beyond demographic and genetic factors. The strong phenotypic and biological predictors are in the cognitive domain (ADAS-Cog; RAVLT), functional domain (FAQ), and neuroimaging domain (middle temporal gyrus and hippocampal volume). The strongest predictor is ADAS-Cog 13 with an increase of one SD in ADAS-Cog 13 increased the risk of AD conversion by 2.92 times. Conclusion: Prediction of AD conversion can be improved by incorporating longitudinal change information, in addition to baseline characteristics. Cognitive measures are consistently significant and generally stronger predictors than imaging measures.",
keywords = "ADNI, joint modeling, longitudinal and survival data, mild cognitive impairment, prediction",
author = "Kan Li and Wenyaw Chan and Doody, {Rachelle S.} and Joseph Quinn and Sheng Luo",
year = "2017",
doi = "10.3233/JAD-161201",
language = "English (US)",
volume = "58",
pages = "361--371",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data

AU - Li, Kan

AU - Chan, Wenyaw

AU - Doody, Rachelle S.

AU - Quinn, Joseph

AU - Luo, Sheng

PY - 2017

Y1 - 2017

N2 - Background: Identifying predictors of conversion to Alzheimer's disease (AD) is critically important for AD prevention and targeted treatment. Objective: To compare various clinical and biomarker trajectories for tracking progression and predicting conversion from amnestic mild cognitive impairment to probable AD. Methods: Participants were from the ADNI-1 study. We assessed the ability of 33 longitudinal biomarkers to predict time to AD conversion, accounting for demographic and genetic factors. We used joint modelling of longitudinal and survival data to examine the association between changes of measures and disease progression. We also employed time-dependent receiver operating characteristic method to assess the discriminating capability of the measures. Results: 23 of 33 longitudinal clinical and imaging measures are significant predictors of AD conversion beyond demographic and genetic factors. The strong phenotypic and biological predictors are in the cognitive domain (ADAS-Cog; RAVLT), functional domain (FAQ), and neuroimaging domain (middle temporal gyrus and hippocampal volume). The strongest predictor is ADAS-Cog 13 with an increase of one SD in ADAS-Cog 13 increased the risk of AD conversion by 2.92 times. Conclusion: Prediction of AD conversion can be improved by incorporating longitudinal change information, in addition to baseline characteristics. Cognitive measures are consistently significant and generally stronger predictors than imaging measures.

AB - Background: Identifying predictors of conversion to Alzheimer's disease (AD) is critically important for AD prevention and targeted treatment. Objective: To compare various clinical and biomarker trajectories for tracking progression and predicting conversion from amnestic mild cognitive impairment to probable AD. Methods: Participants were from the ADNI-1 study. We assessed the ability of 33 longitudinal biomarkers to predict time to AD conversion, accounting for demographic and genetic factors. We used joint modelling of longitudinal and survival data to examine the association between changes of measures and disease progression. We also employed time-dependent receiver operating characteristic method to assess the discriminating capability of the measures. Results: 23 of 33 longitudinal clinical and imaging measures are significant predictors of AD conversion beyond demographic and genetic factors. The strong phenotypic and biological predictors are in the cognitive domain (ADAS-Cog; RAVLT), functional domain (FAQ), and neuroimaging domain (middle temporal gyrus and hippocampal volume). The strongest predictor is ADAS-Cog 13 with an increase of one SD in ADAS-Cog 13 increased the risk of AD conversion by 2.92 times. Conclusion: Prediction of AD conversion can be improved by incorporating longitudinal change information, in addition to baseline characteristics. Cognitive measures are consistently significant and generally stronger predictors than imaging measures.

KW - ADNI

KW - joint modeling

KW - longitudinal and survival data

KW - mild cognitive impairment

KW - prediction

UR - http://www.scopus.com/inward/record.url?scp=85019188282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019188282&partnerID=8YFLogxK

U2 - 10.3233/JAD-161201

DO - 10.3233/JAD-161201

M3 - Article

VL - 58

SP - 361

EP - 371

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -